Molecular biologist, San Raffaele Telethon Institute for Gene Therapy, Milan
Appears in 1 story
Study co-author; co-founded nChroma Bio but holds no official role there
A single injection silenced hepatitis B virus in human liver cells and mice by tagging viral DNA with chemical marks instead of cutting it. The therapy, called CRMA-1001, is now in human trials in Hong Kong and New Zealand, with the first participant dosed in January 2026.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
